undefined

Dali WANG

  • Associate Professor

  • Email address: energywang@sjtu.edu.cn

  • EDUCATION

  • WORKING EXPERIENCE

  • RESEARCH

  • HONORS AND AWARDS

  • PUBLICATIONS

  • 2009-2016   Shanghai Jiao Tong University   Doctor of Philosophy

  • 2005-2009     Donghua University   Bachelor of Science

  • 2022-present  Shanghai Jiao Tong University, School of Chemistry and Chemical Engineering, Associate Professor

  • 2019-2022  Harvard University, Harvard Medical School, Research Fellow

  • 2016-2019  Northeastern University (United States), Department of Chemistry and Chemical Biology, Postdoctoral Research Associate

  • Polymer Chemistry; Biomedical Polymer Materials; Drug Delivery; Nucleic Acid Therapeutics; Gene Therapy

  • 2024 Recipient of First Prize in Science and Technology Progress Award (6/15), China Petroleum and Chemical Industry Federation

  • 2016 Outstanding Graduates of Shanghai, China

  • Wang, D.; Li, Y.; Deng, X.; Torre, M.; Zhang, Z.; Li, X.; Zhang, W.; Cullion, K.; Kohane, D. S.*; Weldon, C. B.*, An aptamer-based depot system for sustained release of small molecule therapeutics. Nat. Commun. 2023, 14, 2444.

  • Wang, D.; Wang, Q.; Wang, Y.; Chen, P.; Lu X.; Jia, F.; Sun, Y.; Sun, T.; Zhang, L.; Che, F.; He, J.; Lian, L.; Morano, G.; Shen, M.;   Ren, M.; Dong, S.; Zhao, J.*; Zhang, K.*, Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides. Proc. Natl. Acad. Sci. U.S.A. 2022, 119, e2113180119.

  • Xu, L.; Yu, C.; Wang, D. *; Pang, J.; Shi, L.; Su, Y.; Gong, L.; Yan, D.; Zhu, X.*, Endogenous nucleotide as drug carrier: base-paired guanosine-5’-monophosphate:   pemetrexed vesicles with enhanced anticancer capability. Sci. China Chem. 2020, 63, 244-253.

  • Wang, D.; Jia, F.; Tan, X.; Wang, Y.; Sun, X.; Cao, X.; Che, F.; Lu, H.; Gao, X.; Shimkonis, J.; Nyoni, Z.; Lu, X.*; Zhang, K.*, Bottlebrush-architectured poly(ethylene glycol) as an efficient vector for RNA interference in vivo. Sci. Adv. 2019, 5, eaav9322.

  • Wang, D.; Yu, C.; Xu, L.; Shi, L.; Tong, G.; Wu, J.; Liu, H.; Yan, D.; Zhu, X.*, Nucleoside analogue based supramolecular nanodrugs driven by molecular recognition for synergistic cancer therapy. J. Am. Chem. Soc. 2018, 140, 8797-8806. (Top 15 Biochemistry Discoveries in 2018)

  • Wang, D.; Liu, B.; Ma, Y.; Wu, C.; Mou, Q.; Deng, H.; Wang, R.; Yan, D.; Zhang, C.*; Zhu, X.*, A molecular recognition approach to synthesize nucleoside analogue based multifunctional nanoparticles for targeted cancer therapy. J. Am. Chem. Soc. 2017, 139, 14021-14024. (Highlighted in Oligonucleotide Therapeutics Society)

  • Wang, D.; Lu, X.; Jia, F.; Tan, X.; Sun, X.; Cao, X.; Wai, F.; Zhang, C.*; Zhang, K.*, Precision tuning of DNA-and poly (ethylene glycol)-based nanoparticles via coassembly for effective antisense gene regulation. Chem. Mater. 2017, 29, 9882-9886.

  • Wang, D.; Jin, Y.; Zhu, X.*; Yan, D.*, Synthesis and applications of stimuli-responsive hyperbranched polymers. Prog. Polym. Sci. 2017, 64, 114-153. (ESI Highly Cited Paper)

  • Wang, D.; Tu, C.; Su, Y.; Zhang, C.; Greiser, U.; Zhu, X.*; Yan, D.; Wang, W.*, Supramolecularly engineered phospholipids constructed by nucleobase molecular recognition: upgraded generation of phospholipids for drug delivery. Chem. Sci. 2015, 6, 3775-3787. (Highlighted in Chemistry World) 10.  Wang, D.; Zhao, T.; Zhu, X.*; Yan, D.; Wang, W.*, Bioapplications of hyperbranched polymers. Chem. Soc. Rev. 2015, 44, 4023-4071. (ESI Highly Cited Paper)